Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1B/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects with Previously Treated Soft-Tissue Sarcomas with Pulmonary Metastases

NCT04887298 is registered in ClinicalTrials.gov with Moleculin Biotech, Inc. as lead sponsor.

NCT NCT04887298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04887298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1B/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects with Previously Treated Soft-Tissue Sarcomas with Pulmonary Metastases
Lead sponsor
Moleculin Biotech, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 5, 2021
Completion date
August 6, 2024
Enrollment
36 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary metastasis, sarcoma,soft tissue